GLP-1 therapies with additional approved indications, such as cardiovascular risk reduction, may be more likely to receive reimbursement
Existing studies have shown that palmitoylation regulates the NOD1/2 signaling pathway by both promoting NOD1/2 membrane translocation and inhibiting and suppressing NOD2 degradation, which together mediate NOD1/2-dependent host defense responses, providing new ideas for the diagnosis and treatment of inflammatory diseases
In addition, patients were not included in the study if they were on a carnitine supplement or on other drugs known to influence lipid metabolism, such as -blockers, glucocorticoids, or lipid-lowering agents during the previous two weeks
In children and adults with significant deficiency, symptoms may involve muscle weakness, exercise intolerance, or cardiac complications
Presented for research literature review only Ingwiller M (2025)